Phase 1 Skin injury Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

Akkermansia Muciniphila (AKK) for Radiation-Induced Skin Injury

Radiation-Induced Skin Injury

West China Hospital40 enrolled2 locationsNCT07635277

Recruiting

Phase 1Phase 2

Phase I-II Clinical Study of Taurine for External Use in the Prevention and Treatment of Acute Radiation Skin Injury

To Evaluate the Safety of Taurine in Preventing Acute Radiation Skin Injury Induced by Adjuvant Radiotherapy in Breast Cancer Patients

Shandong Cancer Hospital and Institute24 enrolled1 locationNCT06847555